Randomized trial of pegylated liposomal doxorubicin (PLD) plus carboplatin versus carboplatin in platinum-sensitive (PS) patients with recurrent epithelial ovarian or peritoneal carcinoma after failure of initial platinum-based chemotherapy (Southwest Oncology Group Protocol S0200)

✍ Scribed by David S. Alberts; P.Y. Liu; Sharon P. Wilczynski; Mary C. Clouser; Ana Maria Lopez; David P. Michelin; Victor J. Lanzotti; Maurie Markman

• Book ID: 113961333
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 163 KB
• Volume: 108
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2007.08.075